Approved comparison material connected to this topic.
6 total recordsSource comparisons are presented without a generated winner.
Different research applications measure different endpoints, and the IGF-1 LR3 results timeline varies accordingly. The table below summarizes expected timelines for the most common outcome measures in peptide…
| Factor | Endogenous IGF-1 | IGF-1 LR3 | Professional Assessment ||—|—|—|| Half-life | 12–15 hours | 20–30 hours | Extended half-life allows once-daily dosing and sustained receptor occupancy without multiple…
IGF-1 LR3 Direct IGF-1 receptor agonist with reduced IGFBP binding Enhanced vascularity, improved pump, glycogen supercompensation, 8–12% FSR increase 20–30 hours Fastest onset of receptor-mediated effects. Ob…
Lean Mass Gain 5–8 kg in 4 weeks 1.5–3 kg (daily dosing, 50–80 mcg) Marketing claims conflate water retention with contractile tissue. Actual myofibrillar protein accretion is slower and requires structured tr…
The most repeated marketing claim is that IGF-1 LR3 causes hyperplasia, meaning new muscle fibers rather than just bigger existing ones. The biology is partly real and partly overstated. IGF-1 does activate sa…
Honest IGF-1 LR3 results are modest. The compound amplifies an existing training and nutrition signal; it does not manufacture a physique. Set expectations against three outcomes that the biology can plausibly…